BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
7/26/2019 10:13:56 AM | Browse: 793 | Download: 1448
 |
Received |
|
2019-03-12 07:36 |
|
Peer-Review Started |
|
2019-03-20 03:54 |
|
To Make the First Decision |
|
2019-04-18 07:01 |
|
Return for Revision |
|
2019-05-13 02:45 |
|
Revised |
|
2019-05-16 16:44 |
|
Second Decision |
|
2019-06-24 03:59 |
 |
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2019-06-27 06:35 |
|
Articles in Press |
|
2019-06-27 06:35 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2019-07-23 00:37 |
|
Publish the Manuscript Online |
|
2019-07-26 10:13 |
| ISSN |
2307-8960 (online) |
| Open Access |
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2019. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Medicine, Research & Experimental |
| Manuscript Type |
Minireviews |
| Article Title |
Current status of the adjuvant therapy in uterine sarcoma: A literature review
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Alessandro Rizzo, Maria Abbondanza Pantaleo, Maristella Saponara and Margherita Nannini |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Margherita Nannini, MD, Academic Research, Doctor, Doctor, Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna, Via Masserenti 9, Bologna, Italy. margherita.nannini@unibo.it., Bologna 40138, Italy. margherita.nannini@unibo.it |
| Key Words |
Uterine sarcoma; Uterine leiomyosarcoma; Endometrial stromal sarcoma; Adenosarcoma; Adjuvant therapy; Chemotherapy |
| Core Tip |
Uterine sarcomas (US) comprise a group of rare mesenchymal tumours with differing tumour biology, natural history and response to treatment. Clinical trials have shown no definite survival benefit of postoperative treatment (neither chemotherapy, nor radiation, nor hormone blockade) although its use seems reasonable in selected cases. This review aims to summarise the current state of knowledge about adjuvant therapy in US. |
| Publish Date |
2019-07-26 10:13 |
| Citation |
Rizzo A, Pantaleo MA, Saponara M, Nannini M. Current status of the adjuvant therapy in uterine sarcoma: A literature review. World J Clin Cases 2019; 7(14): 1753-1763 |
| URL |
https://www.wjgnet.com/2307-8960/full/v7/i14/1753.htm |
| DOI |
https://dx.doi.org/10.12998/wjcc.v7.i14.1753 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
